Mental Health Clinics in Festus, MO Accepting Medicare
25 Mental Health Clinics found. Showing 21 - 25
 Counseling Connections L.l.c. Counselor Medicare: Not Enrolled in Medicare Practice Location: 115 Brierton Ln, Festus, MO 63028 Phone: 636-931-0300 Fax: 636-933-3510 |
Mercy Hospital Jefferson Hospital Units - Psychiatric Unit Medicare: Not Enrolled in Medicare Practice Location: 1400 Us Highway 61, Festus, MO 63028 Phone: 636-933-1000 Fax: 636-933-1136 |
Guided Solutions Counseling & Mediation, Llc Counselor Medicare: Not Enrolled in Medicare Practice Location: 1170a E Gannon Dr, Festus, MO 63028 Phone: 314-602-3968 |
Comtrea, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 227 E Main St, Festus, MO 63028 Phone: 636-931-2700 Fax: 636-931-5304 |
Comtrea Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 227 Main St, Festus, MO 63028 Phone: 636-931-2700 Fax: 636-931-5304 |
News Archive
TU/e researchers image stages of calcification process in atherosclerosis
Atherosclerosis is characterized by hardening and thickening of artery walls, with serious health consequences. Researchers at Eindhoven University of Technology (TU/e) have imaged the stages in the calcification process at a nanometer scale.
Adding quinoa to gluten-free diet of patients with celiac disease is well-tolerated
Adding quinoa to the gluten-free diet of patients with celiac disease is well-tolerated, and does not exacerbate the condition, according to new research published in The American Journal of Gastroenterology. Dr. Victor F. Zevallos, from the Department of Gastroenterology, King's College London, United Kingdom, evaluated the in-vivo effects of consuming quinoa in adult celiac patients. Quinoa, a highly nutritious grain, is traditionally recommended as part of a gluten-free diet.
Precision BioSciences receive $3 million to develop DNE technology
Precision BioSciences, today announced that it has been awarded over $3 million across four government grants. These grants were each awarded to Precision during the 4th Quarter of 2010 and came from the National Institute of Standards and Technology, the Treasury Department, the National Institute of Health, and the State of North Carolina.
University of Florida initiates enrollment in SPI-1005 Phase II trial for sensorineural hearing loss
The University of Florida (UF) has started enrolling subjects in a new study testing the oral drug developed by Sound Pharmaceuticals, Inc. (SPI-1005) to prevent hearing loss caused by loud music. Loud music or noise can induce temporary and permanent auditory threshold shifts (TTS or PTS).
› Verified 2 days ago
- 1
- 2(current)